Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2025)
Curaleaf Holdings (CURLF) recorded quarterly Total Current Liabilities of $294.3 million in Q4 2025, down 24.13% quarter-over-quarter from $387.9 million in Q4 2024, and down 24.13% on a YoY basis from $387.9 million in Q4 2024.
Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $294.3 million for Q4 2025.
- In Q4 2025, Total Current Liabilities fell 24.13% year-over-year to $294.3 million; the TTM figure through Dec 2025 stood at $294.3 million (down 24.13% YoY), while the FY2025 annual figure was $294.3 million, down 24.13% from the prior year.
- Total Current Liabilities was $294.3 million for Q4 2025 at Curaleaf Holdings, down from $387.9 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $436.8 billion in Q1 2022 to a low of $215.3 million in Q2 2021.
- Historically, Total Current Liabilities has averaged $31.6 billion across 5 years, with a median of $385.3 million in 2022.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities surged 183454.65% in 2022, then slumped 31.81% in 2024.
- A 5-year view of Total Current Liabilities shows it stood at $316.2 million in 2021, then surged by 38.16% to $436.9 million in 2022, then grew by 13.07% to $494.0 million in 2023, then decreased by 21.48% to $387.9 million in 2024, then decreased by 24.13% to $294.3 million in 2025.
- The last three Total Current Liabilities figures came in at $294.3 million (Q4 2025), $387.9 million (Q4 2024), and $379.3 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 294.31 Mn |
| Dec 31, 2024 | 387.93 Mn |
| Sep 30, 2024 | 379.26 Mn |
| Jun 30, 2024 | 392.51 Mn |
| Dec 31, 2023 | 494.03 Mn |
| Sep 30, 2023 | 556.21 Mn |
| Jun 30, 2023 | 515.88 Mn |
| Sep 30, 2022 | 436.92 Mn |
| Jun 30, 2022 | 382.65 Mn |
| Mar 31, 2022 | 436.81 Bn |
| Dec 31, 2021 | 316.24 Mn |
| Sep 30, 2021 | 335.21 Mn |
| Jun 30, 2021 | 215.35 Mn |
| Mar 31, 2021 | 237.97 Mn |
| Dec 31, 2020 | 220.13 Mn |
| Sep 30, 2020 | 177.15 Mn |
| Dec 31, 2019 | 106.26 Mn |